[HTML][HTML] Dysregulation of apoptosis in hepatocellular carcinoma cells

I Fabregat - World journal of gastroenterology: WJG, 2009 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a major health problem, being the sixth most common
cancer world-wide. Dysregulation of the balance between proliferation and cell death …

MicroRNA involvement in hepatocellular carcinoma

L Gramantieri, F Fornari, E Callegari… - Journal of cellular …, 2008 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the third cause of cancer‐related death worldwide.
Curative options for HCC are limited and exclusively available for patients carrying an early …

AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway

T Chen, X Dai, J Dai, C Ding, Z Zhang, Z Lin, J Hu… - Cell Death & …, 2020 - nature.com
Hepatocellular carcinoma (HCC) is a major leading cause of cancer-related death
worldwide. Alpha fetoprotein (AFP) is reactivated in a majority of hepatocellular carcinoma …

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway

S Ma, TK Lee, BJ Zheng, KW Chan, XY Guan - Oncogene, 2008 - nature.com
The recent discovery of cancer stem cells (CSCs) has played a pivotal role in changing our
view of carcinogenesis and chemotherapy. Based on this concept, CSCs are responsible for …

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

L Gramantieri, F Fornari, M Ferracin, A Veronese… - Clinical cancer …, 2009 - AACR
Deregulated cell proliferation and apoptosis play a major role in hepatocellular carcinoma
(HCC). MicroRNAs participate in the modulation of key molecules linked to …

Reactive oxygen species-responsive polypeptide drug delivery system targeted activated hepatic stellate cells to ameliorate liver fibrosis

Y Hao, K Song, X Tan, L Ren, X Guo, C Zhou, H Li… - ACS …, 2022 - ACS Publications
Hepatic fibrosis is a chronic liver disease that lacks effective pharmacotherapeutic
treatments. As part of the disease's mechanism, hepatic stellate cells (HSCs) are activated …

Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma

T Amann, F Bataille, T Spruss, M Mühlbauer… - Cancer …, 2009 - Wiley Online Library
Liver cirrhosis is the main risk factor for the development of hepatocellular carcinoma (HCC).
Activated hepatic stellate cells (HSC) are the effector cells of hepatic fibrosis and also …

miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines

CJF Lin, HY Gong, HC Tseng, WL Wang… - … and biophysical research …, 2008 - Elsevier
miR-122, a hepato-specific microRNA (miRNA), is frequently down-regulated in human
hepatocellular carcinoma (HCC). In an effort to identify novel miR-122 targets, we performed …

MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches

E Callegari, L Gramantieri, M Domenicali… - Cell Death & …, 2015 - nature.com
MicroRNAs (miRNAs) constitute a large class of short RNAs (eg, 20–24 nucleotides in
length), whose main function is to posttranscriptionally regulate the expression of protein …

MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis

B Singh, AM Ronghe, A Chatterjee, NK Bhat… - …, 2013 - academic.oup.com
MicroRNAs (miRNA) are small non-coding RNAs that regulate the expression of
approximately 60% of all human genes and play important roles in disease processes …